May 21, 2019 | Congress, Exhibits, exhibition
As I sit here at another pharma conference, I start to reflect on how they have changed over the years.
Back in 2004 I joined an agency that produced exhibition stands/booths for pharmaceutical clients. The beginning of the following year was my first taste of how a booth is designed and run; this was an industry I wasn’t familiar with when I joined. The stand we had built was around 400m2 and had three brands running across it. We had absolutely filled this with interactive technology. Each brand had multiple game stations and six 42” plasma screens with rolling content, all of which we had developed in-house, to educate the delegates on how that particular drug worked in a gamified way.
What I hadn’t realised was how much stuff was being used as giveaways. There were small hand-held digital video cameras, laser pointers, bags, pens, Post-it note pads — you name it, we were probably giving it away. All the games had a high score leaderboard, and if you were at the top of it at the end of the day you could collect one of the more lucrative prizes. (Before you get too excited, this was 2005, so the digital cameras had a whopping two megapixels — yes, two megapixels — which was a real game changer back then.)
Over the three days the stand was always packed. At the breaks it was hard to move from your current position. Delegates would strip you of all the pens and bags you were carrying before you had even made it out of the store room. They came in their droves to play the games, get high scores on the leaderboard for a chance to win to the main prize, and collect as much of the giveaways as they could carry or stuff into a tote bag.
Our client wasn’t the only one doing this — their competitors were all doing the same. The hall was filled with pharma companies, big and small, all trying to sell their products to the prospective customer. It was all about who could attract the most delegates with the most attractive interactive technology, and then send them on their way with as much branded merchandise as possible.
One thing I had noticed is the device companies were all pushed to the outside walls with little pop ups exhibiting their products, trying desperately to be noticed.
For the next few years, we as a company started really pushing what was possible with technology. We hacked Wii controllers Xbox cameras and-adapted PlayStation steering wheels to name but a few, all to create bespoke, mind-blowing attracts for our clients.
Fast forward to 2019. The exhibition hall, in my opinion, is a very different place. The reason is compliance.
These big pharma companies are struggling to attract delegates onto their booths. Once the games, the giveaways and the pens, once known as the doctor’s kryptonite, had been removed, there just wasn’t the draw into the hall anymore.
It seems that the only option they have left is to use large LED displays to promote their products. Yes, there are a few stands that are using VR and AR, but again they are restricted. These attracts must be educational and not a game or content that is rewarded with a prize.
A few of the big Pharma companies have decided against attending these shows as there isn’t the return on investment for them that there used to be. Some have decided to invest more money and time in the symposium and then have only a small presence in the exhibition hall.
On the flip side, the device companies have benefitted from this situation. It has allowed them to have the bigger spaces and a greater presence and at some shows, and they can still give away luxury prizes because they don’t have the same restrictions as pharma1.
So my question is, what can these pharma companies do now to entice the delegates back into the hall and onto their booths? Or are we going to see them remove the booth altogether and just run their workshops independently?
1. Association of British HealthTech Industries. Code of Ethical Business Practice, Chapter 9 A48. July 2018. Available at: http://www.abhicodeofpractice.org.uk/multimedia/New%20Folder/ABHI%20Code%20of%20Business%20Practice%20(final)%20-%20July%202018.pdf. Accessed April 2019.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.
Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, and driving better recruitment and...
Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.
Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.
